TherapeuticsMD shares crater as anticipated M&A deal falls through
Six weeks after announcing an offer to be acquired for nearly $177 million, TherapeuticsMD is now saying the deal is off.
Execs kept it short in a press release, saying proposed buyer EW Healthcare Partners did not acquire the necessary shares to complete the deal by Tuesday night’s deadline. The offer expired as a result, with TherapeuticsMD saying it “intends to maintain normal operations at this time.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.